BiomX
PHGE
13 hedge funds and large institutions have $29.5M invested in BiomX in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 13 → 13 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
0.01% less ownership
Funds ownership: 0.14% → 0.13% (-0.01%)
33% less capital invested
Capital invested by funds: $44M → $29.5M (-$14.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$77.9K |
| 2 |
BlackRock
New York
|
+$22.1K |
| 3 |
RE
RBC Europe
London,
United Kingdom
|
+$10.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.98K |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$3.49K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$258K |
| 2 |
Jane Street
New York
|
-$181K |
| 3 |
Millennium Management
New York
|
-$163K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$116K |
| 5 |
TWMP
Taylor Wealth Management Partners
Boston,
Massachusetts
|
-$6.98K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $12.6M | – | – | – |
|
|
JJIJ
2
Johnson & Johnson Innovation - JJDC
New Brunswick,
New Jersey
| $11.6M | – | – | – |
|
|
3
Millennium Management
New York
| $2.33M | -$163K | -140 | -6% |
|
|
RA
4
Royce & Associates
New York
| $1.96M | – | – | – |
|
|
BCM
5
Bridgeway Capital Management
Houston,
Texas
| $568K | -$116K | -100 | -15% |
|
|
TWMP
6
Taylor Wealth Management Partners
Boston,
Massachusetts
| $174K | -$6.98K | -6 | -3% |
|
|
7
UBS Group
Zurich,
Switzerland
| $77K | +$77.9K | +67 | +957% |
|
|
8
BlackRock
New York
| $31K | +$22.1K | +19 | +173% |
|
9
Morgan Stanley
New York
| $11K | – | – | – |
|
|
RE
10
RBC Europe
London,
United Kingdom
| $9.83K | +$10.5K | +9 | New |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $6K | +$6.98K | +6 | New |
|
|
MI
12
MMCAP International
Grand Cayman,
Cayman Islands
| $3.74K | – | – | – |
|
|
SCM
13
Silverarc Capital Management
Boston,
Massachusetts
| $78 | +$3.49K | +3 | +4% |
|
|
14
Renaissance Technologies
New York
| – | -$258K | -191 | Closed |
|
|
15
Jane Street
New York
| – | -$181K | -134 | Closed |
|
PHGE Hedge Fund Activity: Q2 2021 in Review
13 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q2 2021, worth a combined $29.5M — down 33% from $44M a quarter earlier.
Fund positioning in PHGE was balanced in Q2 2021: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, adding an estimated $77.9K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $258K sold.
- 13 institutional investors held BiomX (PHGE) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $29.5M of BiomX stock for Q2 2021, down 33% quarter-over-quarter.
- 2 funds opened new BiomX positions in Q2 2021 and 2 closed out, a net change of 0 holders.
- The largest BiomX buyer in Q2 2021 was UBS Group, an estimated $77.9K added.
- The largest BiomX seller in Q2 2021 was Renaissance Technologies, an estimated $258K sold.
Based on aggregated 13F filings for Q2 2021.